Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Penicillin Allergy Assessment & Skin Testing (PAAST) Certificate Program


Live Session Available on February 22, 2019 in Columbia, South Carolina
 
This comprehensive program is designed to develop and hone skills of healthcare providers in allergy assessment and penicillin skin testing for the purpose of improving antibiotic selection and patient outcomes following allergy reconciliation. 
 
This 15-hour continuing education accredited program combines interactive and in-depth home study (11 hours) with live programming (4 hours) led by faculty who are among the nation’s leading physician and pharmacist experts and scholars in penicillin allergy related outcomes and execution of comprehensive allergy assessment and skin testing.  ACPE, AACME, and ANCC continuing education credit will be issued upon successful completion of the entire program (see below for details).
 
Target Audience:  Any healthcare provider involved in antibiotic administration, prescribing, and/or decision-making including nurses, pharmacists, nurse practitioners, physician assistants, and physicians.
 
_______________________________________________________________________________________________________________________________________________________________________________________________
 
Home Study Information
 
The home study component of the certificate program consists of 10 modules followed by a mandatory post-test.  Prior to attendance at a live session, all participants must view all home study materials, pass the post-test, and complete an evaluation of the home study content.  Please note that no continuing education credit is awarded for completion of the home study modules without completion of a live session.  You must register for and complete a live session in order to recieve continuing education credit.
 
Module Name
Module Faculty
Module Length
Learning Objectives
At the completion of this activity, participants will be able to:
Penicillin Allergy: Classification, Immunology and Cross-reactivity
Justin Chen, MD;
Adult and Pediatric Allergist, East Texas Allergy & Asthma Associates
1.25 hours
 
  1. Distinguish drug allergy from other adverse drug reactions
  2. Describe the immunologic basis of drug and penicillin allergies
  3. Review penicillin sensitization risk following treatment and over time
  4. Assess cross-reactivity between penicillin and related β-lactams
When beta-lactams are best: assessment of primary infectious diseases and organisms where beta-lactams are preferred
Christopher M. Bland, PharmD; Clinical Associate Professor, University of Georgia College of Pharmacy
1.5 hours
 
  1. Define beta-lactams for purposes relevant to penicillin allergy and treatment choices
  2. Identify infectious diseases where beta-lactams are preferred therapies for management
  3. Summarize key studies demonstrating clear evidence for beta-lactam superiority in common infectious diseases
  4. Evaluate specific pathogens for which beta-lactams are preferred therapy
  5. Outline areas where beta-lactams are preferred for antimicrobial prophylaxis
  6. Differentiate between penicillins and cephalosporins for treatment of specific infectious diseases and/or pathogens
The Scarlet Label: Effects of the Penicillin Allergy Label on Infectious and Antibiotic-Associated Outcomes
Mary Staicu, PharmD; Infectious Diseases Clinical Pharmacy Specialist, Rochester General Hospital
1 hour
  1. Compare infectious outcomes in penicillin-allergic versus non-penicillin-allergic patients
  2. Identify consequences associated with the use of non-β-lactam antibiotics in penicillin-allergic patients
  3. Appraise the financial implications associated with the penicillin allergy label
Journal Club & Critical Literature Evaluation: The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk
Emily Heil, PharmD; Assistant Professor, University of Maryland School of Pharmacy; Antimicrobial Stewardship Program Pharmacy Director, University of Maryland Medical Center
1 hour
  1. Apply knowledge of study designs and statistical methods to the appraisal of a clinical study on risk of surgical site infection in patients with and without reported penicillin allergy
  2. Identify the strengths and limitations of a retrospective cohort study design in assessing the association between penicillin allergies and surgical site infections
  3. Evaluate the clinical applicability of reported penicillin allergy in the selection of antibiotic surgical prophylaxis
How to Complete a Penicillin Allergy Assessment
Brandon Bookstaver, PharmD; Associate Professor, University of South Carolina College of Pharmacy; ID Pharmacist, Palmetto Health Richland
 
Hana Rac, PharmD; Clinical Instructor, University of South Carolina College of Pharmacy; Lead Antimicrobial Stewardship Pharmacist, Antimicrobial Stewardship Collaborative of South Carolina (ASC-SC)
0.5 hours
  1. Value the importance of appropriate drug allergy assessment
  2. Recognize pertinent questions to ask to complete an effective penicillin allergy assessment
Managing patients with reported penicillin allergies
Luis Tulloch, MD; Clinical Assistant Professor of Medicine, University of Washington
1.0 hours
  1. Recognize the indications for penicillin allergy interventions
  2. Compare and contrast the procedural aspects and performance parameters of graded challenges and penicillin desensitization as alternatives to penicillin skin testing
  3. Recommend an appropriate management strategy for a patient with a reported penicillin allergy
A Detailed Description of Penicillin Allergy Skin Testing (PAST): Kit Preparation, Administration and Interpretation
Nicholas Torney, PharmD; Co-Director, Antimicrobial Stewardship Program, Munson Medical Center
0.75 hours
  1. Define the utility and limitations of PAST, including contraindications to PAST
  2. Identify the PAST kit contents and recall their preparation and storage requirements
  3. Describe the process of conducting a PAST, including anticipatory guidance to patients about what to expect from testing
  4. Interpret the results of a PAST
Implementing a Penicillin Skin Testing Program
Bruce Jones, PharmD; Infectious Diseases Clinical Pharmacy Specialist, St. Joseph’s/Candler Health System
1 hour
  1. Outline state and federal regulations for penicillin skin testing programs
  2. Define the key elements of a protocol detailing the steps to complete penicillin skin testing
  3. Analyze current literature on implementation of penicillin skin testing
  4. Compare and contrast different types of penicillin skin testing programs
  5. Explore initial steps for an individual facility to implement a penicillin skin testing program based on available resources
Journal Club & Critical Literature Evaluation: Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs
Brandon Bookstaver, PharmD
 
Hana Rac, PharmD
 
See above for titles and positions
1 hour
 
  1. Apply knowledge of study designs and statistical methods to the appraisal of the clinical study on β-lactam skin testing
  2. Assess β-lactam skin testing as an antimicrobial stewardship tool using the peer reviewed literature
  3. Describe evidence-based study outcomes related to implementation of β-lactam skin testing
Assessment and Penicillin Skin Testing Services in Your Health-System: Lessons Learned in the Trenches
Geoffrey Wall, PharmD; Professor, College of Pharmacy at Drake University; Director, Drake Drug Information Center
1 hour
  1. Describe the clinical and financial outcomes of allergy assessment programs based off local experience
  2. Recognize common barriers to starting an allergy assessment program including potential regulatory, system, and departmental hurdles
  3. Review case examples of allergy assessment programs
Post-Test
All program faculty
1 hour
All participants will be required to pass a post-test on the material covered within the modules prior to attending the live session.
 
_______________________________________________________________________________________________________________________________________________________________________________________________
 
Live Session Information
 
Host Organization:  University of South Carolina College of Pharmacy
Date: Friday, January 25, 2019
Time:  12:30 pm to 4:30 pm
Location:  University of South Carolina College of Pharmacy, Coker Life Sciences Building, 715 Sumter Street, Columbia, South Carolina, 29201 (after registering, please expand the "Live Session" tab below to view parking and room location information)
Registration Fee (includes home study and continuing education credit):  $199
Student Registration Fee (includes home study, does not include continuing education credit):  $99
 
Faculty
Length
Live Program Learning Objectives
At the completion of this activity, participants will be able to:
Brandon Bookstaver, PharmD; Associate Professor, University of South Carolina College of Pharmacy; ID Pharmacist, Palmetto Health Richland
 
Hana Rac, PharmD; Clinical Instructor, University of South Carolina College of Pharmacy; Lead Antimicrobial Stewardship Pharmacist, Antimicrobial Stewardship Collaborative of South Carolina (ASC-SC)
4 hours
  1. Perform a patient-specific comprehensive allergy assessment
  2. Evaluate the need for penicillin skin testing based on results of comprehensive allergy assessment
  3. Execute a penicillin skin test according to approved labeling and best practices
  4. Interpret results of a penicillin skin test according to approved labeling and best practices
  5. Justify the value of penicillin skin testing in acute care and ambulatory antimicrobial stewardship programs
  6. Value the importance of documentation, data collection and scholarship opportunities related to penicillin allergies and antimicrobial outcomes
  7. Assess profession-specific state regulations regarding penicillin skin testing
  8. Develop an outline for an institution-specific penicillin skin testing protocol
  9. Formulate a needs assessment for implementation of an institution protocol for penicillin skin testing 
 
_______________________________________________________________________________________________________________________________________________________________________________________________

Date: Feb 22, 2019 12:30 PM - 04:30 PM

Fee

$199.00

CE Hours

15.00

CE Units

1.500

Registration closes on Feb 21, 2019 11:30 PM

Activity Type

  • Practice Based

Requirements for CE Credit

Pharmacy (ACPE):
 The University of South Carolina is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This is a practice-based activity which is accredited for a total of 15 contact hours (1.5 CEUs) for pharmacists (UAN 0062-9999-19-002-B01-P).  Initial release date: January 5, 2019; expiration date: January 5, 2022.
In order to complete this practice-based program, all pharmacists are required to view all home study modules in their entirety (participating in active learning components as prompted), pass the home study post-test (prior to attending the live session), and attend a live session in its entirety. Credit will not be awarded for completing only the home study modules if a live session is not attended, and credit will not be awarded for completing only the live session if the home study modules are not completed and the post-test is not passed.  In order to have credit reported to the NABP CPE Monitor, participants must complete the online program evaluations within 30 days of the live activity and must provide their correct NABP e-profile number and day/month of birth. Any credit claimed greater than 60 days from the date of the live activity will be automatically rejected by the NABP CPE Monitor.

Medicine (ACCME):
Accreditation Statement:  This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical University of South Carolina and the University of South Carolina College of Pharmacy.  The Medical University of South Carolina is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation:  The Medical University of South Carolina designates the live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™.  The Medical University of South Carolina designates the enduring activity for a maximum of 11 AMA PRA Category 1 Credit(s)™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (ANCC): 
Mid-Carolina AHEC, Inc. is an approved provider of continuing nursing education by the South Carolina Nurse Association, an accredited approver with distinction, by the American Nurses Credentialing Center’s Commission on Accreditation.  This nursing continuing education activity approval #1811-032PR-011 has been approved for 15.0 hours.

Support/Credits

This program is supported by an unrestricted educational grant from ALK-Abello, Inc.
 
Disclosures
  • Christopher Bland, PharmD, has served as a speaker for ALK, TetraPhase, Merck, and bioMérieux.  He has served on an advisory board for Paratek.  He has received grant funding from Merck.
  • Brandon Bookstaver, PharmD, has served as a speaker for Melinta Therapeutics. He has served on advisory boards for Cutis Pharma, Melinta Therapeutics, and Synthetic Biologics.  He has received travel grant support from ALK.
  • Justin Chen, MD, has served as a speaker for ALK.  He has served on an advisory panel for AstraZeneca.
  • Emily Heil, PharmD, has received research grant support from ALK.
  • Bruce Jones, PharmD, has served as a speaker for Allergan, Tetraphase, and bioMérieux.  He has received grant funding from ALK.  He has consulted for ALK and Paratek.
  • Jamie Kisgen, PharmD, has served as a speaker for Merck.
  • Eric Macy, MD, has received a received research grant support from ALK.  He has served on a data and safety monitoring board for Audentes.
  • Hana Rac, PharmD, has served as a speaker for ALK.
  • Mary Staicu, PharmD, has served on an advisory board for ALK.
  • Nicholas Torney, PharmD, has served as a speaker for ALK.  He has received educational and travel grant support from ALK.
  • Geoffrey Wall, PharmD, has served as a speaker for Janssen Pharmaceuticals, Boehringer Ingelheim, and La Jolla Pharmaceuticals.  He has received grant support from ALK.
     
  • All other individuals involved in the development of this material declare no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.  
     
  • Conflicts of interest have been resolved by Caitlin Mardis, PharmD, BCPS, Director of Continuing Education at the University of South Carolina College of Pharmacy, through peer content review by at least two unconflicted reviewers.  The unconflicted reviewer panel consisted of Caitlin Mardis, PharmD; Brandon Dionne, PharmD; Megan Jeffres, PharmD; Shyam Joshi, MD; Julie Ann Justo, PharmD, MS; Mildred Kwan, MD; Krutika Mediwala, PharmD; Nathon Parker, PharmD; Sheena Patel, MD; and Michael Tiberg, PharmD.
_______________________________________________________________________________________________________________________________________________________________________________________________
 
 
 
 
Please click on each of the bars below to access module specifics including the module faculty, length, and learning objectives.
 
The home study modules, materials, and instructions are also available below if you have registered for the program.

Please choose a Fee Type from the Drop Down Menu Below:
I am a
 

 

Registration closes on Feb 21, 2019 at 11:30 PM

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
Penicillin Allergy: Classification, Immunology and Cross-reactivity
Justin Chen, MD;
Adult and Pediatric Allergist, East Texas Allergy & Asthma Associates
1.25 hours
  1. Distinguish drug allergy from other adverse drug reactions
  2. Describe the immunologic basis of drug and penicillin allergies
  3. Review penicillin sensitization risk following treatment and over time
  4. Assess cross-reactivity between penicillin and related β-lactams

Registration Closed  

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
When beta-lactams are best: assessment of primary infectious diseases and organisms where beta-lactams are preferred
Christopher M. Bland, PharmD; Clinical Associate Professor, University of Georgia College of Pharmacy
1.5 hours
  1. Define beta-lactams for purposes relevant to penicillin allergy and treatment choices
  2. Identify infectious diseases where beta-lactams are preferred therapies for management
  3. Summarize key studies demonstrating clear evidence for beta-lactam superiority in common infectious diseases
  4. Evaluate specific pathogens for which beta-lactams are preferred therapy
  5. Outline areas where beta-lactams are preferred for antimicrobial prophylaxis
  6. Differentiate between penicillins and cephalosporins for treatment of specific infectious diseases and/or pathogens

Registration Closed  

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
The Scarlet Label: Effects of the Penicillin Allergy Label on Infectious and Antibiotic-Associated Outcomes
Mary Staicu, PharmD; Infectious Diseases Clinical Pharmacy Specialist, Rochester General Hospital
1.0 hours
  1. Compare infectious outcomes in penicillin-allergic versus non-penicillin-allergic patients
  2. Identify consequences associated with the use of non-β-lactam antibiotics in penicillin-allergic patients
  3. Appraise the financial implications associated with the penicillin allergy label

Registration Closed  

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
Journal Club & Critical Literature Evaluation: The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk
Emily Heil, PharmD; Assistant Professor, University of Maryland School of Pharmacy; Antimicrobial Stewardship Program Pharmacy Director, University of Maryland Medical Center
1.0 hours
  1. Apply knowledge of study designs and statistical methods to the appraisal of a clinical study on risk of surgical site infection in patients with and without reported penicillin allergy
  2. Identify the strengths and limitations of a retrospective cohort study design in assessing the association between penicillin allergies and surgical site infections
  3. Evaluate the clinical applicability of reported penicillin allergy in the selection of antibiotic surgical prophylaxis

Registration Closed  

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
How to Complete a Penicillin Allergy Assessment
Brandon Bookstaver, PharmD; Associate Professor, University of South Carolina College of Pharmacy; ID Pharmacist, Palmetto Health Richland
 
Hana Rac, PharmD; Clinical Instructor, University of South Carolina College of Pharmacy; Lead Antimicrobial Stewardship Pharmacist, Antimicrobial Stewardship Collaborative of South Carolina (ASC-SC)
0.5 hours
  1. Value the importance of appropriate drug allergy assessment
  2. Recognize pertinent questions to ask to complete an effective penicillin allergy assessment

Registration Closed  

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
Managing patients with reported penicillin allergies
Luis Tulloch, MD; Clinical Assistant Professor of Medicine, University of Washington
1.0 hours
  1. Recognize the indications for penicillin allergy interventions
  2. Compare and contrast the procedural aspects and performance parameters of graded challenges and penicillin desensitization as alternatives to penicillin skin testing
  3. Recommend an appropriate management strategy for a patient with a reported penicillin allergy

Registration Closed  

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
A Detailed Description of Penicillin Allergy Skin Testing (PAST): Kit Preparation, Administration and Interpretation
Nicholas Torney, PharmD; Co-Director, Antimicrobial Stewardship Program, Munson Medical Center
0.75 hours
  1. Define the utility and limitations of PAST, including contraindications to PAST
  2. Identify the PAST kit contents and recall their preparation and storage requirements
  3. Describe the process of conducting a PAST, including anticipatory guidance to patients about what to expect from testing
  4. Interpret the results of a PAST

Registration Closed  

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
Implementing a Penicillin Skin Testing Program
Bruce Jones, PharmD; Infectious Diseases Clinical Pharmacy Specialist, St. Joseph’s/Candler Health System
1.0 hours
  1. Outline state and federal regulations for penicillin skin testing programs
  2. Define the key elements of a protocol detailing the steps to complete penicillin skin testing
  3. Analyze current literature on implementation of penicillin skin testing
  4. Compare and contrast different types of penicillin skin testing programs
  5. Explore initial steps for an individual facility to implement a penicillin skin testing program based on available resources

Registration Closed  

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
Journal Club & Critical Literature Evaluation: Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs
Brandon Bookstaver, PharmD; Associate Professor, University of South Carolina College of Pharmacy; ID Pharmacist, Palmetto Health Richland
 
Hana Rac, PharmD; Clinical Instructor, University of South Carolina College of Pharmacy; Lead Antimicrobial Stewardship Pharmacist, Antimicrobial Stewardship Collaborative of South Carolina (ASC-SC)
1 hour
  1. Apply knowledge of study designs and statistical methods to the appraisal of the clinical study on β-lactam skin testing
  2. Assess β-lactam skin testing as an antimicrobial stewardship tool using the peer reviewed literature
  3. Describe evidence-based study outcomes related to implementation of β-lactam skin testing

Registration Closed  

Registration Closed  

Module Title
Module Faculty
Module Length
Module Learning Objectives
At the completion of this activity, participants will be able to:
Assessment and Penicillin Skin Testing Services in Your Health-System: Lessons Learned in the Trenches
Geoffrey Wall, PharmD; Professor, College of Pharmacy at Drake University; Director, Drake Drug Information Center
1 hour
  1. Describe the clinical and financial outcomes of allergy assessment programs based off local experience
  2. Recognize common barriers to starting an allergy assessment program including potential regulatory, system, and departmental hurdles
  3. Review case examples of allergy assessment programs

Registration Closed  

Registration Closed  

After viewing each home study module, ensure that you complete the evaluation of each home study module by selecting the "Complete Evaluation" button to the right of the module name.  You will be asked to enter the evaluation access code which was provided on the final slide of the module.  These evaluations must be completed prior to attending your live session and prior to your CE credit being issued by the ACPE, AACME, or ANCC provider.
 
After viewing all of the home study module videos, please select the green "Take the Test" button and enter the post-test access code from the final slide of Module 10 to access the home study post-test.  You must achieve a passing score (>80%) on this 45 question test in order to proceed to the live session.  You will be given the opportunity to retake the test if you do not achieve a passing score.

Registration Closed  

Registration Closed  

Live Session Faculty  Length
Live Session Learning Objectives
At the completion of this activity, participants will be able to:
Brandon Bookstaver, PharmD; Associate Professor, University of South Carolina College of Pharmacy; ID Pharmacist, Palmetto Health Richland
 
Hana Rac, PharmD; Clinical Instructor, University of South Carolina College of Pharmacy; Lead Antimicrobial Stewardship Pharmacist, Antimicrobial Stewardship Collaborative of South Carolina (ASC-SC)
4 hours
  1. Perform a patient-specific comprehensive allergy assessment
  2. Evaluate the need for penicillin skin testing based on results of comprehensive allergy assessment
  3. Execute a penicillin skin test according to approved labeling and best practices
  4. Interpret results of a penicillin skin test according to approved labeling and best practices
  5. Justify the value of penicillin skin testing in acute care and ambulatory antimicrobial stewardship programs
  6. Value the importance of documentation, data collection and scholarship opportunities related to penicillin allergies and antimicrobial outcomes
  7. Assess profession-specific state regulations regarding penicillin skin testing
  8. Develop an outline for an institution-specific penicillin skin testing protocol
  9. Formulate a needs assessment for implementation of an institution protocol for penicillin skin testing 
 
 
At the conclusion of the live session, a live session evaluation will become available on this site.  You must complete the live session evaluation in order to claim the 15 hours of continuing education credit for the program as a whole.  Pharmacist credit will be submitted automatically to the NABP CPE Monitor upon completion of the evaluation, whereas CME and ANCC credit will be issued by these providers at that time.

Activity Number

0062-9999-19-002-B01-P
Date: 02/22/19
Time: 12:30 PM - 04:30 PM

CE Hours

15.00
Registration Closed